Literature DB >> 24880049

Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins.

Nils Helge Schebb1, Annika I Ostermann2, Jun Yang3, Bruce D Hammock3, Andreas Hahn4, Jan Philipp Schuchardt4.   

Abstract

INTRODUCTION: It is believed that many of the beneficial effects of long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) are mediated by their oxidized metabolites, the oxylipins. The formation and biological role of many cytochrome P450 and lipoxygenase derived hydroxy, epoxy and dihydroxy FA, particularly of oxylipins esterified in polar lipids and triglycerides remain unclear. In this study, we compared the impact of twelve weeks of LC n-3 PUFA supplementation on the patterns of free and total (sum of esterified and free) hydroxy, epoxy and dihydroxy FAs. SUBJECTS AND METHODS: Subjects (5 male; 5 female) between 46 and 70 years were supplemented with 1.1g/d of eicosapentaenoic acid (EPA) and 0.74g/d docosahexaenoic acid (DHA) as ethyl esters. Blood samples were drawn before and after twelve weeks of treatment. Oxylipins in plasma were analyzed by LC-MS directly for free oxylipins and after saponification. Relative FA composition in erythrocyte membranes was analyzed by GC.
RESULTS: LC n-3 PUFA treatment led to a significant increase in EPA (200%) and DHA (23%) in erythrocyte membranes. Of the oxylipins measured in plasma, total and free EPA-derived metabolites were highly increased (70-150%), while total AA-derived metabolites were decreased on average by 30%. There was no effect on DHA-metabolites. Concentrations of total hydroxy and epoxy FAs in plasma were considerably higher compared to free hydroxy and epoxy FAs (up to 350 times), while levels of most free dihydroxy FAs were in a similar range to total dihydroxy FAs. However, the individual ratios between total and free plasma oxylipins remained unchanged after LC n-3 PUFA treatment. DISCUSSION AND
CONCLUSIONS: LC n-3 PUFA supplementation causes a shift in the levels of circulating oxylipins, having the strongest impact on EPA-derived epoxy, dihydroxy and hydroxy FA. The unchanged ratio of free and esterified oxylipins in plasma indicates that both concentrations are valuable biomarkers for assessing the individual status of these lipid mediators.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; DHA; Diols; EPA; Eicosanoids; Epoxides; Omega-3 fatty acids; PUFA

Mesh:

Substances:

Year:  2014        PMID: 24880049      PMCID: PMC4247815          DOI: 10.1016/j.prostaglandins.2014.05.002

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  38 in total

1.  Rethinking lipid mediators.

Authors:  Karsten H Weylandt; Jing X Kang
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.

Authors:  Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2014-03-16       Impact factor: 5.922

Review 3.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

4.  Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.

Authors:  Cosima Arnold; Marija Markovic; Katrin Blossey; Gerd Wallukat; Robert Fischer; Ralf Dechend; Anne Konkel; Clemens von Schacky; Friedrich C Luft; Dominik N Muller; Michael Rothe; Wolf-Hagen Schunck
Journal:  J Biol Chem       Date:  2010-08-23       Impact factor: 5.157

5.  Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation.

Authors:  F Jung; C Schulz; F Blaschke; D N Muller; C Mrowietz; R P Franke; A Lendlein; W-H Schunck
Journal:  Clin Hemorheol Microcirc       Date:  2012       Impact factor: 2.375

Review 6.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 7.  Cyclooxygenases: structural and functional insights.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

8.  Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat.

Authors:  John W Newman; George A Kaysen; Bruce D Hammock; Gregory C Shearer
Journal:  J Lipid Res       Date:  2007-05-11       Impact factor: 5.922

9.  Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils.

Authors:  W S Powell; S Gravel; F Gravelle
Journal:  J Lipid Res       Date:  1995-12       Impact factor: 5.922

10.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.

Authors:  Pao-Yen Lin; Kuan-Pin Su
Journal:  J Clin Psychiatry       Date:  2007-07       Impact factor: 4.384

View more
  23 in total

1.  Dietary Docosahexaenoic Acid and trans-10, cis-12-Conjugated Linoleic Acid Differentially Alter Oxylipin Profiles in Mouse Periuterine Adipose Tissue.

Authors:  Yuriko Adkins; Benjamin J Belda; Theresa L Pedersen; Dawn M Fedor; Bruce E Mackey; John W Newman; Darshan S Kelley
Journal:  Lipids       Date:  2017-04-13       Impact factor: 1.880

2.  Lipidomic Analysis of Oxidized Fatty Acids in Plant and Algae Oils.

Authors:  Christine E Richardson; Marie Hennebelle; Yurika Otoki; Daisy Zamora; Jun Yang; Bruce D Hammock; Ameer Y Taha
Journal:  J Agric Food Chem       Date:  2017-02-28       Impact factor: 5.279

3.  Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs.

Authors:  Shan Leng; Tanja Winter; Harold M Aukema
Journal:  J Lipid Res       Date:  2017-06-30       Impact factor: 5.922

4.  Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.

Authors:  Jeffrey Kim; Arzu Ulu; Debin Wan; Jun Yang; Bruce D Hammock; Robert H Weiss
Journal:  Mol Cancer Ther       Date:  2016-02-26       Impact factor: 6.261

5.  Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin.

Authors:  Elani F Wiest; Mary T Walsh-Wilcox; Michael Rothe; Wolf-Hagen Schunck; Mary K Walker
Journal:  Toxicol Sci       Date:  2016-08-04       Impact factor: 4.849

6.  The effects of omega-3 fatty acid deficiency during development on oxidative fatty acid degradation during maturity in a mouse model of Alzheimer's disease.

Authors:  Ran Furman; Paul H Axelsen
Journal:  Neurobiol Aging       Date:  2019-03-23       Impact factor: 4.673

Review 7.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

8.  Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study.

Authors:  Marie Hennebelle; Yurika Otoki; Jun Yang; Bruce D Hammock; Anthony J Levitt; Ameer Y Taha; Walter Swardfager
Journal:  Psychiatry Res       Date:  2017-02-27       Impact factor: 3.222

9.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

10.  Time Course and Sex Effects of α-Linolenic Acid-Rich and DHA-Rich Supplements on Human Plasma Oxylipins: A Randomized Double-Blind Crossover Trial.

Authors:  Melissa Gabbs; Peter Zahradka; Carla G Taylor; Harold M Aukema
Journal:  J Nutr       Date:  2021-03-11       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.